Trademark: 78136573
Status Date
Sunday, October 29, 2006
Filing Date
Tuesday, June 18, 2002
Published for Opposition
Tuesday, August 5, 2003
Abandoned Date
Sunday, October 29, 2006
5 Biopharmaceuticals for use in the diagnosis, prevention, and treatment of human and animal diseases, namely cancer, viral infections, microbial infections, autoimmune diseases, allergies, immunological dysfunctions, neurological disorders, blood disorders, and inflammatory diseases
Jan 4, 2007
Abandonment Notice Mailed - No Use Statement Filed
Jan 4, 2007
Abandonment - No Use Statement Filed
Apr 24, 2006
Extension 5 Granted
Apr 24, 2006
Extension 5 Filed
Apr 24, 2006
Teas Extension Received
Feb 15, 2006
Extension 4 Granted
Oct 28, 2005
Extension 4 Filed
Jan 23, 2006
Extension Received With Teas Petition
Jan 23, 2006
Petition To Revive-Granted
Jan 23, 2006
Teas Petition To Revive Received
Jan 4, 2006
Abandonment Notice Mailed - No Use Statement Filed
Jan 4, 2006
Abandonment - No Use Statement Filed
Jun 1, 2005
Assigned To Examiner
May 31, 2005
Assigned To Examiner
Apr 8, 2005
Extension 3 Granted
Apr 8, 2005
Extension 3 Filed
Apr 8, 2005
Teas Extension Received
Mar 21, 2005
Assigned To Examiner
Mar 8, 2005
Assigned To Examiner
Mar 7, 2005
Assigned To Examiner
Jan 18, 2005
Extension 2 Granted
Oct 28, 2004
Extension 2 Filed
Jan 5, 2005
Extension Received With Teas Petition
Jan 5, 2005
Petition To Revive-Granted
Jan 5, 2005
Teas Petition To Revive Received
Aug 19, 2004
Case File In Ticrs
Nov 14, 2003
Extension 1 Granted
Nov 5, 2003
Extension 1 Filed
Nov 5, 2003
Teas Extension Received
Oct 28, 2003
Noa Mailed - Sou Required From Applicant
Aug 5, 2003
Published For Opposition
Jul 16, 2003
Notice Of Publication
Jun 3, 2003
Approved For Pub - Principal Register
Apr 10, 2003
Correspondence Received In Law Office
Apr 10, 2003
Teas Response To Office Action Received
Oct 22, 2002
Non-Final Action E-Mailed
Oct 7, 2002
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
